BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28684164)

  • 61. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
    Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
    Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
    J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8(+) memory T cell production capacity of these cells in vivo.
    Jeong YJ; Kim JH; Hong JM; Kang JS; Kim HR; Lee WJ; Hwang YI
    Immunobiology; 2014 Jul; 219(7):554-64. PubMed ID: 24698552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
    Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
    J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
    Boudousquié C; Danilo M; Pousse L; Jeevan-Raj B; Angelov GS; Chennupati V; Zehn D; Held W
    J Immunol; 2014 Sep; 193(6):2784-91. PubMed ID: 25127860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
    Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor-Associated Monocytes Reprogram CD8
    Yang Z; Liu L; Zhu Z; Hu Z; Liu B; Gong J; Jin Y; Luo J; Deng Y; Jin Y; Wang G; Yin Y
    Adv Sci (Weinh); 2024 Apr; 11(16):e2304501. PubMed ID: 38386350
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.
    Shibayama Y; Tsukahara T; Emori M; Murata K; Mizushima E; Hirohashi Y; Kanaseki T; Nakatsugawa M; Kubo T; Yamashita T; Sato N; Torigoe T
    Cancer Sci; 2017 Sep; 108(9):1739-1745. PubMed ID: 28699227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulating immune memory and reversing tumor thermotolerance through a step-by-step starving-photothermal therapy.
    Luo L; Qin B; Jiang M; Xie L; Luo Z; Guo X; Zhang J; Li X; Zhu C; Du Y; Peng L; You J
    J Nanobiotechnology; 2021 Sep; 19(1):297. PubMed ID: 34593005
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytotoxic Efficiency of Human CD8
    Knörck A; Schäfer G; Alansary D; Richter J; Thurner L; Hoth M; Schwarz EC
    Front Immunol; 2022; 13():838484. PubMed ID: 35493468
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Promoting thiol expression increases the durability of antitumor T-cell functions.
    Kesarwani P; Al-Khami AA; Scurti G; Thyagarajan K; Kaur N; Husain S; Fang Q; Naga OS; Simms P; Beeson G; Voelkel-Johnson C; Garrett-Mayer E; Beeson CC; Nishimura MI; Mehrotra S
    Cancer Res; 2014 Nov; 74(21):6036-6047. PubMed ID: 25164014
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neem Leaf Glycoprotein Restrains VEGF Production by Direct Modulation of HIF1α-Linked Upstream and Downstream Cascades.
    Saha A; Nandi P; Dasgupta S; Bhuniya A; Ganguly N; Ghosh T; Guha I; Banerjee S; Baral R; Bose A
    Front Oncol; 2020; 10():260. PubMed ID: 32211322
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IL-7R licenses a population of epigenetically poised memory CD8
    Micevic G; Daniels A; Flem-Karlsen K; Park K; Talty R; McGeary M; Mirza H; Blackburn HN; Sefik E; Cheung JF; Hornick NI; Aizenbud L; Joshi NS; Kluger H; Iwasaki A; Bosenberg MW; Flavell RA
    Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2304319120. PubMed ID: 37459511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of naïve and central memory derived CD8
    Wang X; Wong CW; Urak R; Taus E; Aguilar B; Chang WC; Mardiros A; Budde LE; Brown CE; Berger C; Forman SJ; Jensen MC
    Oncoimmunology; 2016; 5(1):e1072671. PubMed ID: 26942092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Akt1 and -2 inhibition diminishes terminal differentiation and enhances central memory CD8
    Abu Eid R; Friedman KM; Mkrtichyan M; Walens A; King W; Janik J; Khleif SN
    Oncoimmunology; 2015 May; 4(5):e1005448. PubMed ID: 26155399
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting CD8
    Wang Y; Zeng Y; Yang W; Wang X; Jiang J
    Phytomedicine; 2024 Jul; 129():155608. PubMed ID: 38642413
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Replicative history marks transcriptional and functional disparity in the CD8
    Bresser K; Kok L; Swain AC; King LA; Jacobs L; Weber TS; Perié L; Duffy KR; de Boer RJ; Scheeren FA; Schumacher TN
    Nat Immunol; 2022 May; 23(5):791-801. PubMed ID: 35393592
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT.
    Li L; Kim HT; Nellore A; Patsoukis N; Petkova V; McDonough S; Politikos I; Nikiforow S; Soiffer R; Antin JH; Ballen K; Cutler C; Ritz J; Boussiotis VA
    Blood Cancer J; 2014 Jan; 4(1):e178. PubMed ID: 24442207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.